HotMed.info

Rabeprazole

Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. It was developed by Eisai Co. and is marketed by Janssen-Cilag as rabeprazole sodium under the brand names Aciphex and Pariet. Pharmacology Rabeprazole is a prodrug (metabolized by the cytochrome P450 (or CYP450)) - in the acid environment of the parietal cells it turns into [...]

Continue reading...

Rosiglitazone

Rosiglitazone is an anti-diabetic drug in the thiazolidinedione class of drugs. It is marketed by the pharmaceutical company GlaxoSmithKline as a stand-alone drug (Avandia) and in combination with metformin (Avandamet) or with glimepiride (Avandaryl). Recent findings suggest that Rosiglitazone is associated with a statistically significant risk of myocardial ischemic events.[1][2]

Continue reading...

Rituximab

Rituximab, sold under the trade names Rituxan and MabThera, is a chimeric monoclonal antibody used in the treatment of B cell non-Hodgkin’s lymphoma, B cell leukemia, and some autoimmune disorders. History Rituximab was developed by IDEC Pharmaceuticals and initially approved by the FDA in 1997 for

Continue reading...

Risperidone

Risperidone (pronounced Ris-PER-ǐ-dōn and sold under the trade name Risperdal in the Netherlands, United States, Canada, the United Kingdom, Portugal and several other countries, Risperdal or Ridal in New Zealand, Rispolept in Eastern Europe, and Belivon, or Rispen elsewhere) is an atypical antipsychotic medication developed by Janssen-Cilag.

Continue reading...